PMDA drug package insert
アリドネパッチ27.5mg
PMDA Prescription drug · 帝國製薬株式会社 · package insert Apr 1, 2025
Key facts
| Brand names | アリドネパッチ27.5mg, アリドネパッチ55mg |
|---|---|
| Nonproprietary names | ドネペジル |
| Companies | 製造販売元／帝國製薬株式会社, 販売元／興和株式会社 |
| Product type | Prescription drug |
| Therapeutic category | アルツハイマー型認知症治療剤 |
| Therapeutic category codes | 87119 |
| YJ codes | 1190701S1023, 1190701S2020 |
| Approval numbers | 30400AMX00451, 30400AMX00452 |
| Package insert edition | 第4版 |
| Package insert date | Apr 1, 2025 |
| PMDA document key | 470006_1190701S1023_1 |
| PMDA company code | 470006 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: